Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: Effective palliation

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Martin, Robert C G ^a,b,c   Philips, Prejesh ^a,b,c   Ellis, Susan ^a,b,c   Hayes, David ^a,b,c   Bagla, Sandeep ^a,b,c  

^a University of Louisville School of Medicine   (United States)

^b Baptist Hospital   (United States)

^c Department of Interventional Radiology INOVA   (Egypt)

Author keywords

Irreversible electroporation; Liver tumors; Locally advanced tumors; Pancreatic tumors; Safety; Vascular invasion

Indexed keywords

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; ELECTROPORATION; FEMALE; HUMAN; IRREVERSIBLE ELECTROPORATION; IRREVERSIBLE ELECTROPORATION DEVICE; LOCAL RECURRENCE FREE SURVIVAL; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PALLIATIVE THERAPY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; SOFT TISSUE TUMOR; TUMOR INVASION; TUMOR VOLUME; ABDOMINAL ABSCESS; ADVANCED CANCER; BILE LEAKAGE; CANCER GRADING; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CHOLESTASIS; CLINICAL EFFECTIVENESS; FOLLOW UP; ILEUS; LIVER FAILURE; MORBIDITY; MULTICENTER STUDY; NAUSEA AND VOMITING; PANCREAS DISEASE; PEROPERATIVE COMPLICATION; PNEUMONIA; SURVIVAL RATE; SYNDROME DELINEATION; THERAPY EFFECT; TUMOR ABLATION; WOUND INFECTION; ABLATION THERAPY; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PROCEDURES; SOFT TISSUE NEOPLASMS; SURVIVAL; TREATMENT OUTCOME;

ABLATION TECHNIQUES; ELECTROPORATION; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PALLIATIVE CARE; PROSPECTIVE STUDIES; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84904779018     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-540     Document Type: Article

References (21)

1. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. Embo J 1982, 1:841-845. 553119, 6329708.
2. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005, 33:223-231. 10.1007/s10439-005-8981-8, 15771276.
3. Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 2007, 6:307-312.
4. Bower M, Sherwood L, Li Y, Martin R. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol 2011, 104:22-28. 10.1002/jso.21899, 21360714.
5. Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE. Irreversible electroporation of the liver and liver hilum in swine. HPB (Oxford) 2011, 13:168-173. 3048967, 21309933.
6. Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE. Irreversible electroporation of the pancreas in swine: a pilot study. HPB (Oxford) 2010, 12:348-351. 2951824, 20590911.
7. Cannon R, Ellis S, Hayes D, Narayanan G, Martin RC. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 2013, 107:544-549. 10.1002/jso.23280, 23090720.
8. Martin RC, McFarland K, Ellis S, Velanovich V. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. J Am Coll Surg 2012, 215:361-369. 10.1016/j.jamcollsurg.2012.05.021, 22726894.
9. Martin RC, McFarland K, Ellis S, Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol 2012, 20(Suppl 3):S443-S449.
10. Martin RC. Irreversible electroporation of locally advanced pancreatic head adenocarcinoma. J Gastrointest Surg 2013, 17(10):1850-1856. 10.1007/s11605-013-2309-z, 23929188.
11. Martin RCG. Irreversible electroporation: a novel option for treatment of hepatic metastases. Curr Colorectal Cancer Rep 2013, 9:191-197.
12. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:205-216. 10.1093/jnci/92.3.205, 10655437.
13. Grambsch PM, Therneau TM, Fleming TR. Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics 1995, 51:1469-1482. 10.2307/2533277, 8589234.
14. Chang DC, Reese TS. Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy. Biophys J 1990, 58:1-12. 10.1016/S0006-3495(90)82348-1, 1280935, 2383626.
15. Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST, Wong J. Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 2004, 239:441-449. 10.1097/01.sla.0000118565.21298.0a, 1356248, 15024304.
16. Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Learning curve for percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: a prospective study of 70 consecutive cases. Ann Surg Oncol 2006, 13:1588-1595. 10.1245/s10434-006-9010-3, 16957970.
17. Thomson KR, Cheung W, Ellis SJ, Federman D, Kavnoudias H, Loader-Oliver D, Roberts S, Evans P, Ball C, Haydon A. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 2011, 22:611-621. 10.1016/j.jvir.2010.12.014, 21439847.
18. Hildebrand P, Leibecke T, Kleemann M, Mirow L, Birth M, Bruch HP, Burk C. Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcome. Eur J Surg Oncol 2006, 32:430-434. 10.1016/j.ejso.2006.01.006, 16520015.
19. Orgera G, Krokidis M, Monfardini L, Bonomo G, Della Vigna P, Fazio N, Orsi F. High intensity focused ultrasound ablation of pancreatic neuroendocrine tumours: report of two cases. Cardiovasc Intervent Radiol 2011, 34:419-423. 10.1007/s00270-010-9884-0, 20521049.
20. Orsi F, Zhang L, Arnone P, Orgera G, Bonomo G, Vigna PD, Monfardini L, Zhou K, Chen W, Wang Z, Veronesi U. High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations. AJR Am J Roentgenol 2010, 195:W245-W252. 10.2214/AJR.09.3321, 20729423.
21. Zhang L, Zhu H, Jin C, Zhou K, Li K, Su H, Chen W, Bai J, Wang Z. High-intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol 2009, 19:437-445. 10.1007/s00330-008-1137-0, 18795303.